According to our acRIP-sequencing (acRIP-seq) assay, NAT10-mediated ac4C modification may promote HNSCC tumor progression by regulating the MAPK pathway (Fig. 4F). The gene discussed is NAT10; the disease is head and neck squamous cell carcinoma.